Body mass index (BMI) and breast cancer: Impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women

Nicoletta Biglia, Elisa Peano, Paola Sgandurra, Giulia Moggio, Silvia Pecchio, Furio Maggiorotto, Piero Sismondi

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The study aims to analyze the association between body mass index (BMI) at time of diagnosis, breast cancer histopathologic features (tumor size, nuclear grade, estrogen and progesterone receptor (ER and PgR) and HER-2/neu expression, histological subtypes, Ki-67 index, lymphatic/vascular invasion, axillary nodes involvement) and incidence of different subtypes defined using hormone receptors and HER2/neu expression, according to menopausal status; to evaluate the impact of BMI on disease free survival (DFS) at multivariate analysis. A total of 2148 patients (592 premenopausal, 1556 postmenopausal) were classified into subgroups according to BMI distribution. High BMI was significantly associated with larger size tumor both in pre (p = 0.01) and postmenopausal women (p = 0.00). Obese premenopausal women showed worse histopathologic features (more metastatic axillary lymphnodes, p = 0.017 and presence of vascular invasion, p = 0.006) compared to under/normal weight group. Postmenopausal patients with BMI > 25 developed more frequently ER/PgR positive cancers (87% versus 75%, p 0.017), while no association was found in premenopausal women. We could not found any statistically significant correlation between breast cancer subtypes (luminal A, B, HER-2 and basal-like) and BMI both in pre and postmenopause. Higher BMI was significantly associated with a shorter DR-FS in postmenopausal women but the independent prognostic role of obesity was not confirmed in our analysis.

Original languageEnglish
Pages (from-to)263-267
Number of pages5
JournalGynecological Endocrinology
Volume29
Issue number3
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Body Mass Index
Breast Neoplasms
Recurrence
Neoplasms
Blood Vessels
ErbB-2 Receptor
Postmenopause
Progesterone Receptors
Cytoplasmic and Nuclear Receptors
Estrogen Receptors
Disease-Free Survival
Multivariate Analysis
Obesity
Hormones
Weights and Measures
Incidence

Keywords

  • Body mass index
  • Breast cancer
  • Estrogen receptor
  • Menopause

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Obstetrics and Gynaecology

Cite this

Body mass index (BMI) and breast cancer : Impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women. / Biglia, Nicoletta; Peano, Elisa; Sgandurra, Paola; Moggio, Giulia; Pecchio, Silvia; Maggiorotto, Furio; Sismondi, Piero.

In: Gynecological Endocrinology, Vol. 29, No. 3, 03.2013, p. 263-267.

Research output: Contribution to journalArticle

@article{5f1b4cd3cd30487e84ea33cce032c571,
title = "Body mass index (BMI) and breast cancer: Impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women",
abstract = "The study aims to analyze the association between body mass index (BMI) at time of diagnosis, breast cancer histopathologic features (tumor size, nuclear grade, estrogen and progesterone receptor (ER and PgR) and HER-2/neu expression, histological subtypes, Ki-67 index, lymphatic/vascular invasion, axillary nodes involvement) and incidence of different subtypes defined using hormone receptors and HER2/neu expression, according to menopausal status; to evaluate the impact of BMI on disease free survival (DFS) at multivariate analysis. A total of 2148 patients (592 premenopausal, 1556 postmenopausal) were classified into subgroups according to BMI distribution. High BMI was significantly associated with larger size tumor both in pre (p = 0.01) and postmenopausal women (p = 0.00). Obese premenopausal women showed worse histopathologic features (more metastatic axillary lymphnodes, p = 0.017 and presence of vascular invasion, p = 0.006) compared to under/normal weight group. Postmenopausal patients with BMI > 25 developed more frequently ER/PgR positive cancers (87{\%} versus 75{\%}, p 0.017), while no association was found in premenopausal women. We could not found any statistically significant correlation between breast cancer subtypes (luminal A, B, HER-2 and basal-like) and BMI both in pre and postmenopause. Higher BMI was significantly associated with a shorter DR-FS in postmenopausal women but the independent prognostic role of obesity was not confirmed in our analysis.",
keywords = "Body mass index, Breast cancer, Estrogen receptor, Menopause",
author = "Nicoletta Biglia and Elisa Peano and Paola Sgandurra and Giulia Moggio and Silvia Pecchio and Furio Maggiorotto and Piero Sismondi",
year = "2013",
month = "3",
doi = "10.3109/09513590.2012.736559",
language = "English",
volume = "29",
pages = "263--267",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Body mass index (BMI) and breast cancer

T2 - Impact on tumor histopatologic features, cancer subtypes and recurrence rate in pre and postmenopausal women

AU - Biglia, Nicoletta

AU - Peano, Elisa

AU - Sgandurra, Paola

AU - Moggio, Giulia

AU - Pecchio, Silvia

AU - Maggiorotto, Furio

AU - Sismondi, Piero

PY - 2013/3

Y1 - 2013/3

N2 - The study aims to analyze the association between body mass index (BMI) at time of diagnosis, breast cancer histopathologic features (tumor size, nuclear grade, estrogen and progesterone receptor (ER and PgR) and HER-2/neu expression, histological subtypes, Ki-67 index, lymphatic/vascular invasion, axillary nodes involvement) and incidence of different subtypes defined using hormone receptors and HER2/neu expression, according to menopausal status; to evaluate the impact of BMI on disease free survival (DFS) at multivariate analysis. A total of 2148 patients (592 premenopausal, 1556 postmenopausal) were classified into subgroups according to BMI distribution. High BMI was significantly associated with larger size tumor both in pre (p = 0.01) and postmenopausal women (p = 0.00). Obese premenopausal women showed worse histopathologic features (more metastatic axillary lymphnodes, p = 0.017 and presence of vascular invasion, p = 0.006) compared to under/normal weight group. Postmenopausal patients with BMI > 25 developed more frequently ER/PgR positive cancers (87% versus 75%, p 0.017), while no association was found in premenopausal women. We could not found any statistically significant correlation between breast cancer subtypes (luminal A, B, HER-2 and basal-like) and BMI both in pre and postmenopause. Higher BMI was significantly associated with a shorter DR-FS in postmenopausal women but the independent prognostic role of obesity was not confirmed in our analysis.

AB - The study aims to analyze the association between body mass index (BMI) at time of diagnosis, breast cancer histopathologic features (tumor size, nuclear grade, estrogen and progesterone receptor (ER and PgR) and HER-2/neu expression, histological subtypes, Ki-67 index, lymphatic/vascular invasion, axillary nodes involvement) and incidence of different subtypes defined using hormone receptors and HER2/neu expression, according to menopausal status; to evaluate the impact of BMI on disease free survival (DFS) at multivariate analysis. A total of 2148 patients (592 premenopausal, 1556 postmenopausal) were classified into subgroups according to BMI distribution. High BMI was significantly associated with larger size tumor both in pre (p = 0.01) and postmenopausal women (p = 0.00). Obese premenopausal women showed worse histopathologic features (more metastatic axillary lymphnodes, p = 0.017 and presence of vascular invasion, p = 0.006) compared to under/normal weight group. Postmenopausal patients with BMI > 25 developed more frequently ER/PgR positive cancers (87% versus 75%, p 0.017), while no association was found in premenopausal women. We could not found any statistically significant correlation between breast cancer subtypes (luminal A, B, HER-2 and basal-like) and BMI both in pre and postmenopause. Higher BMI was significantly associated with a shorter DR-FS in postmenopausal women but the independent prognostic role of obesity was not confirmed in our analysis.

KW - Body mass index

KW - Breast cancer

KW - Estrogen receptor

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=84874340180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874340180&partnerID=8YFLogxK

U2 - 10.3109/09513590.2012.736559

DO - 10.3109/09513590.2012.736559

M3 - Article

C2 - 23174088

AN - SCOPUS:84874340180

VL - 29

SP - 263

EP - 267

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 3

ER -